Cargando…
Jadenu(®) Substituting Exjade(®) in Iron Overloaded β-Thalassemia Major (BTM) Patients: A Preliminary Report of the Effects on the Tolerability, Serum Ferritin Level, Liver Iron Concentration and Biochemical Profiles
INTRODUCTION: Due to the chronic nature of chelation therapy and the adverse consequences of iron overload, patient adherence to therapy is an important issue. Jadenu (®) is a new oral formulation of deferasirox (Exjade (®)) tablets for oral suspension. While Exjade(®) is a dispersible tablet that m...
Autores principales: | Yassin, Mohamed A, Soliman, Ashraf T, De Sanctis, Vincenzo, Hussein, Radwa M, Al-Okka, Randa, Kassem, Nancy, Ghasoub, Rula, Basha, Ahmed, Nashwan, Abdulqadir J, Adel, Ahmad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223544/ https://www.ncbi.nlm.nih.gov/pubmed/30416696 http://dx.doi.org/10.4084/MJHID.2018.064 |
Ejemplares similares
-
Deferasirox (Exjade®) significantly improves cardiac T2* in heavily iron-overloaded patients with β-thalassemia major
por: Pathare, Anil, et al.
Publicado: (2009) -
Statural growth and prevalence of endocrinopathies in relation to liver iron content (LIC) in adult patients with beta thalassemia major (BTM) and sickle cell disease (SCD)
por: Yassin, Mohamed A, et al.
Publicado: (2018) -
Iron Overload in Chronic Kidney Disease: Less Ferritin, More T2(*)MRI
por: Nashwan, Abdulqadir J., et al.
Publicado: (2022) -
Severe Liver Iron Concentrations (LIC) in 24 Patients with β-Thalassemia Major: Correlations with Serum Ferritin, Liver Enzymes and Endocrine Complications
por: Kanbour, Ibrahim, et al.
Publicado: (2018) -
Exjade® (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion
por: Cappellini, Maria Domenica
Publicado: (2007)